Cargando…

The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis

BACKGROUD: Resection is still the only potentially curative treatment for patients with intrahepatic cholangiocarcinoma (ICC), but the prognosis remains far from satisfactory. However, the benefit of adjuvant therapy (AT) remains controversial, although it has been conducted prevalently. Hence, a me...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Qiao, Lin, Nanping, Deng, Manjun, Wang, Lei, Zeng, Yongyi, Liu, Jingfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034847/
https://www.ncbi.nlm.nih.gov/pubmed/32084210
http://dx.doi.org/10.1371/journal.pone.0229292
_version_ 1783499954784829440
author Ke, Qiao
Lin, Nanping
Deng, Manjun
Wang, Lei
Zeng, Yongyi
Liu, Jingfeng
author_facet Ke, Qiao
Lin, Nanping
Deng, Manjun
Wang, Lei
Zeng, Yongyi
Liu, Jingfeng
author_sort Ke, Qiao
collection PubMed
description BACKGROUD: Resection is still the only potentially curative treatment for patients with intrahepatic cholangiocarcinoma (ICC), but the prognosis remains far from satisfactory. However, the benefit of adjuvant therapy (AT) remains controversial, although it has been conducted prevalently. Hence, a meta-analysis was warranted to evaluate the effect of AT for patients with ICC after resection. PATIENTS AND METHODS: PubMed, MedLine, Embase, the Cochrane Library, Web of Science were used to identify potentially eligible studies from Jan.1(st) 1990 to Aug. 31(st) 2019, investigating the effect of AT for patients with ICC after resection. Primary endpoint was overall survival (OS), and secondary endpoints was recurrence-free survival (RFS). Hazard ratio (HR) with 95% confidence interval (CI) was used to determine the effect size. RESULTS: 22 studies with 10181 patients were enrolled in this meta-analysis, including 832 patients in the chemotherapy group, 309 patients in the transarterial chemoembolization (TACE) group, 1192 patients in the radiotherapy group, 235 patients in the chemoradiotherapy group, and 6424 patients in the non-AT group. The pooled HR for the OS rate and RFS rate in the AT group were 0.63 (95%CI 0.52~0.74), 0.74 (95%CI 0.58~0.90), compared with the non-AT group. Subgroup analysis showed that the pooled HR for the OS rate in the AT group compared with non-AT group were as follows: chemotherapy group was 0.57 (95%CI = 0.44~0.70), TACE group was 0.56 (95%CI = 0.31~0.82), radiotherapy group was 0.71 (95%CI = 0.39~1.03), chemoradiotherapy group was 0.73 (95%CI = 0.57~0.89), positive resection margin group was 0.60 (95%CI = 0.51~0.69), and lymph node metastasis (LNM) group was 0.67 (95%CI = 0.57~0.76). CONCLUSION: With the current data, we concluded that AT such as chemotherapy, TACE and chemoradiotherapy could benefit patients with ICC after resection, especially those with positive resection margin and LNM, but the conclusion needed to be furtherly confirmed.
format Online
Article
Text
id pubmed-7034847
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-70348472020-02-27 The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis Ke, Qiao Lin, Nanping Deng, Manjun Wang, Lei Zeng, Yongyi Liu, Jingfeng PLoS One Research Article BACKGROUD: Resection is still the only potentially curative treatment for patients with intrahepatic cholangiocarcinoma (ICC), but the prognosis remains far from satisfactory. However, the benefit of adjuvant therapy (AT) remains controversial, although it has been conducted prevalently. Hence, a meta-analysis was warranted to evaluate the effect of AT for patients with ICC after resection. PATIENTS AND METHODS: PubMed, MedLine, Embase, the Cochrane Library, Web of Science were used to identify potentially eligible studies from Jan.1(st) 1990 to Aug. 31(st) 2019, investigating the effect of AT for patients with ICC after resection. Primary endpoint was overall survival (OS), and secondary endpoints was recurrence-free survival (RFS). Hazard ratio (HR) with 95% confidence interval (CI) was used to determine the effect size. RESULTS: 22 studies with 10181 patients were enrolled in this meta-analysis, including 832 patients in the chemotherapy group, 309 patients in the transarterial chemoembolization (TACE) group, 1192 patients in the radiotherapy group, 235 patients in the chemoradiotherapy group, and 6424 patients in the non-AT group. The pooled HR for the OS rate and RFS rate in the AT group were 0.63 (95%CI 0.52~0.74), 0.74 (95%CI 0.58~0.90), compared with the non-AT group. Subgroup analysis showed that the pooled HR for the OS rate in the AT group compared with non-AT group were as follows: chemotherapy group was 0.57 (95%CI = 0.44~0.70), TACE group was 0.56 (95%CI = 0.31~0.82), radiotherapy group was 0.71 (95%CI = 0.39~1.03), chemoradiotherapy group was 0.73 (95%CI = 0.57~0.89), positive resection margin group was 0.60 (95%CI = 0.51~0.69), and lymph node metastasis (LNM) group was 0.67 (95%CI = 0.57~0.76). CONCLUSION: With the current data, we concluded that AT such as chemotherapy, TACE and chemoradiotherapy could benefit patients with ICC after resection, especially those with positive resection margin and LNM, but the conclusion needed to be furtherly confirmed. Public Library of Science 2020-02-21 /pmc/articles/PMC7034847/ /pubmed/32084210 http://dx.doi.org/10.1371/journal.pone.0229292 Text en © 2020 Ke et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ke, Qiao
Lin, Nanping
Deng, Manjun
Wang, Lei
Zeng, Yongyi
Liu, Jingfeng
The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis
title The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis
title_full The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis
title_fullStr The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis
title_full_unstemmed The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis
title_short The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis
title_sort effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: a systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034847/
https://www.ncbi.nlm.nih.gov/pubmed/32084210
http://dx.doi.org/10.1371/journal.pone.0229292
work_keys_str_mv AT keqiao theeffectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis
AT linnanping theeffectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis
AT dengmanjun theeffectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis
AT wanglei theeffectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis
AT zengyongyi theeffectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis
AT liujingfeng theeffectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis
AT keqiao effectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis
AT linnanping effectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis
AT dengmanjun effectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis
AT wanglei effectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis
AT zengyongyi effectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis
AT liujingfeng effectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis